✦ LIBER ✦

Advocacy group claims lack of drug innovation

Book ID: 127171143
Publisher: American Chemical Society
Year: 1978
Tongue: English
Weight: 138 KB
Volume: 56
Category: Article
ISSN: 0009-2347
DOI: 10.1021/cen-v056n014.p007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of patient advocacy: the case

The impact of patient advocacy: the case of innovative breast cancer drug reimbursement

✍ Roel Nahuis; Wouter P.C. Boon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Drug Dependence: Lack of Knowledge

📂 Article 📅 1971 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Defense Lawyers Fear Impact of Cali Case

Defense Lawyers Fear Impact of Cali Case: Attorneys' indictment for aiding drug clients could chill advocacy, critics claim

✍ HENRY J. RESKE 📂 Article 📅 1995 🏛 American Bar Association 🌐 English ⚖ 337 KB

Old Drug, New Use: Article of Manufactur

Old Drug, New Use: Article of Manufacture Claims

✍ Kelly, Patrick D. 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 208 KB

Drug Development: The role of innovation

Drug Development: The role of innovation in drug development

✍ Drews, Jürgen; Ryser, Stefan 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 296 KB

Azithromycin and terfenadine: Lack of dr

Azithromycin and terfenadine: Lack of drug interaction*

✍ Harris, Stuart; Hilligoss, Donald M.; Colangelo, Philip M.; Eller, Mark; Okerhol 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 637 KB

## Azithromycin and terfenadine: Lack of drug interaction A double-blind placebo-controlled study was conducted in healthy men to determine the effect of coadministration of azithromycin on the pharmacodynamics and pharmacokinetics of terfenadhre. Administration of 500 mg azithromycin for 1 day an